RiverVest Venture Partners, a Clayton-based venture capital firm specializing in the life sciences sector, has raised $167.5 for a new fund.
The fund, which is the fourth from RiverVest, was launched in late 2017 with a target of $150 million.
Jay Schmelter, John McKearn and Niall O’Donnell, all managing directors at RiverVest, are listed as the fund’s executive officers.
RiverVest, founded in 2000, has close to 40 portfolio companies and has exited 20 companies.
Read more: St. Louis Post-Dispatch